|
|
|
|
Drawing on insights from the global regulatory landscape, industry trends, and direct feedback from customers, Dr. Di Wu addresses some of the most frequently asked questions about drug delivery, specifically, on-body delivery system (OBDS) requirements.
|
|
|
|
|
Bringing a combination drug–delivery product to patients involves a highly complex series of steps beyond the drug development cycle itself. Simplify the complexity of combination product development by partnering for integrated support across device design, industrialization, manufacturing, and final product assembly.
|
|
|
|
|
|
|
Successfully advancing a drug-delivery device to market demands more than technical expertise; it requires coordinated execution, regulatory insight, and the ability to scale without disruption.
|
|
|
|
|
|
|
From early concept and device development through analytical testing, clinical supply, and commercial manufacturing, we bring the expertise and infrastructure needed to keep programs moving forward.
|
|
|
|
|
|
|
|
|
Meet West at PDA Miniverse in Dublin, Ireland from May 21-22. Team Members will be at Stand #17 to learn about West’s newest offerings, including West Vantage. To schedule a meeting, please email meetwest@westpharma.com.
|
|
|
